Cunningham Nicole J, Beymer Matthew R, Javanbakht Marjan, Shover Chelsea L, Bolan Robert K
Department of Health and Mental Health Services, Los Angeles LGBT Center, Los Angeles, California, USA.
Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, California, USA.
Sex Transm Infect. 2017 Nov;93(7):514-519. doi: 10.1136/sextrans-2016-052933. Epub 2017 May 29.
HIV studies and risk assessments among men who have sex with men (MSM) frequently use self-reported STI history as a proxy for true STI history. The objective of our study was to assess the validity of self-reported STI history through comparison with laboratory-confirmed biomedical results.
Data were analysed for MSM attending the Los Angeles LGBT Center (the Center) from August 2011 to July 2015. We identified 10 529 unique MSM who received testing for chlamydia, gonorrhoea and/or syphilis and had a later visit in which they self-reported their STI history to a clinic counsellor during a risk assessment.
MSM who had an STI in the past year self-reported their STI history with 51%-56% accuracy, and MSM who had an STI more than a year ago self-reported their STI history with 65%-72% accuracy. Among MSM with any positive STIs at the Center, black/African-American and Hispanic MSM were more likely to inaccurately self-report their positive results for gonorrhoea (adjusted OR (aOR): 1.48, 95% CI 1.09 to 2.01; aOR: 1.39, 95% CI 1.14 to 1.70). Additionally, HIV-positive MSM were more likely to inaccurately self-report their positive results for gonorrhoea (aOR: 1.63, 95% CI 1.22 to 2.18) and/or syphilis (aOR: 2.19, 95% CI 1.08 to 4.47).
This is the first study that attempts to evaluate the validity of self-reported STI history among MSM. We found that self-reported STI history may not be an appropriate proxy for true STI history in certain settings and minority populations. Clinical guidelines and research studies that rely on self-reported STI history will need to modify their recommendations in light of the limited validity of these data.
男男性行为者(MSM)中的HIV研究和风险评估经常将自我报告的性传播感染(STI)病史作为真实STI病史的替代指标。我们研究的目的是通过与实验室确诊的生物医学结果进行比较,评估自我报告的STI病史的有效性。
对2011年8月至2015年7月在洛杉矶 LGBT 中心(该中心)就诊的MSM的数据进行分析。我们确定了10529名接受衣原体、淋病和/或梅毒检测且后来在风险评估期间向诊所咨询师自我报告其STI病史的独特MSM。
过去一年有STI的MSM自我报告其STI病史的准确率为51%-56%,而一年多前有STI 的MSM自我报告其STI病史的准确率为65%-72%。在该中心任何STI呈阳性的MSM中,黑人/非裔美国人和西班牙裔MSM更有可能不准确地自我报告其淋病阳性结果(调整后的比值比(aOR):1.48,95%可信区间1.09至2.01;aOR:1.39,95%可信区间1.14至1.70)。此外,HIV阳性的MSM更有可能不准确地自我报告其淋病(aOR:1.63,95%可信区间1.22至2.18)和/或梅毒(aOR:2.19,95%可信区间1.08至4.47)阳性结果。
这是第一项试图评估MSM中自我报告的STI病史有效性的研究。我们发现,在某些环境和少数族裔人群中,自我报告的STI病史可能不是真实STI病史的合适替代指标。鉴于这些数据的有效性有限,依赖自我报告的STI病史的临床指南和研究需要修改其建议。